| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.21 | 0.0004 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.18 | 0.004 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.004 |